Lv4
480 积分 2023-05-12 加入
Loss of payload sensitivity and other mechanisms of resistance to T-DXd in HER2-mutant NSCLC: implications for subsequent responsiveness to HER2 TKIs
24天前
已完结
Trastuzumab rezetecan, a HER2-directed antibody–drug conjugate, in patients with advanced HER2-mutant non-small-cell lung cancer (HORIZON-Lung): phase 2 results from a multicentre, single-arm study
1个月前
已完结
Trastuzumab rezetecan, a HER2-directed antibody–drug conjugate, in patients with advanced HER2-mutant non-small-cell lung cancer (HORIZON-Lung): phase 2 results from a multicentre, single-arm study
3个月前
已完结
Drug Induced Interstitial Lung Disease
4个月前
已完结
Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities
6个月前
已完结
Molecular subtypes of small cell lung cancer: a synthesis of human and mouse model data
6个月前
已完结
Emerging advances in defining the molecular and therapeutic landscape of small-cell lung cancer
6个月前
已完结
Small cell lung cancer profiling: an updated synthesis of subtypes, vulnerabilities, and plasticity
7个月前
已完结
U3-1402 sensitizes HER3-expressing tumors to PD-1 blockade by immune activation
7个月前
已完结
The Therapeutic Significance of HER3 in Non-small Cell Lung Cancer (NSCLC): A Review Study
7个月前
已完结
皖公网安备34019202002308
